GLP1 receptor agonists are insulinogenic, which means they stimulate the pancreas to release insulin, which drives sugar out of the blood and into the cells, where it belongs
Each ingredient on its own has a substantial body of preclinical literature
Developed by Eli Lilly and currently in Phase 3 clinical trials, it functions as a triple agonist, simultaneously activating three distinct receptor types that regulate appetite, metabolism, and energy expenditure
The compound answers your question while simultaneously introducing new confounders
Robert Kushner, Professor of Medicine at Northwestern University, explains: "We consider the patients goals and values into account along with discussions of risk and benefits." This means your tapering plan will be unique to your situation, even if youre on the same medication as someone else
Patients also describe experiencing changes in taste, smell, and digestion while on Mounjaro or Wegovy, leading to questions about why these effects occur and how they can be managed